1[1]Neutel JM,Smith DHG.Evaluation of angiotensin Ⅱ recep tor blockers for 24-hour blood control:meta-analysis of a clinic database[J].J Clin Hypertens,2003,5 (1):58-63.
2[2]Parati G,Kempthome-Rawson J,Zaniboni D,et al.Distribution of blood pressure reduction by treatment over the 24h:comparative assessment of the effect of different drugs by the smoothness index[J].J Hypertens,2001,19 Supppl 2:S174.
3[3]Abuissa H,Jones PG,Marso SP,et al.Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes:A recta-analysis of randomized clinical trials[J].J Am Coll Cardiol,2005,46(5):821-826.
4[4]Negro R,Hassan H.The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic,hypertensive patients[J].J Renin Angiotensin Aldosterone Syst,2007,7 (4):243-246.
5[5]Kwan Yi Chu,Tung Lau,Carlsson PO,et al.Angiotensin Ⅱ type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes[J].Diabetes,2006,55 (2):367-374.
6[6]Sharma AM,Janke J,Gorzelniak K,et al.Aagiotensin blockade prevents type 2 diabetes by formation of fat cells[J].Hypertension,2002,40 (5):609-611.
7[7]Araki K,Masaki T,Katsuragi I,et al.Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice[J].Hypertension,2006,48(1):51-57.
9[9]Benson SC,Pershadsingh HA,Ho I,et al.Identification of telmisartan as a unique angiotensin Ⅱ receptor antagonist with selective PPABγ-modulating activity[J].Hypertension,2004,43 (5):993-1002.
10[10]Marshall TG,Lee BE,Marshall FE.Common angiotensin receptor blockers may directly modulate the immune system via VDR,PPAR and CCR2b[J].Theor Biol Med Model,2006,3(1):1-33.
